Conversely, inhibiting the NLRP3 inflammasome has demonstrated a protective effect against atrial fibrillation caused by cardiovascular aging [17], as well as overload-induced cardiac hypertrophy [18]. This evidence concerns the gene NLRP3 and cardiac hypertrophy.